PegBeLiver study : HBsAg decline at week 24 of extended Peginterferon Alfa-2A (PEG-IFNα-2a) therapy is significantly associated with post-treatment response in HBeAg-negative genotype D patients

Lampertico, P.; Vigano', M.; Galeota Lanza, A.; Sagnelli, E.; Fasano, M.; Di Marco, V.; Bininsegna, S.; Farci, P.; Fargion, S.R.; Giuberti, T.; Iannacone, C.; Massetto, B.; Martins, E.B.; Colombo, M.

PegBeLiver study : HBsAg decline at week 24 of extended Peginterferon Alfa-2A (PEG-IFNα-2a) therapy is significantly associated with post-treatment response in HBeAg-negative genotype D patients / P. Lampertico, M. Vigano', A. Galeota Lanza, E. Sagnelli, M. Fasano, V. Di Marco, S. Bininsegna, P. Farci, S.R. Fargion, T. Giuberti, C. Iannacone, B. Massetto, E.B. Martins, M. Colombo. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 54:Suppl. 1(2011 Mar), pp. S293-S293. ((Intervento presentato al 46. convegno The International Liver Congress™ : Annual Meeting of the European Association for the Study of the Liver (EASL) tenutosi a Berlin nel 2011.